432 related articles for article (PubMed ID: 30152521)
1. Understanding the tumour micro-environment communication network from an NOS2/COX2 perspective.
Basudhar D; Bharadwaj G; Somasundaram V; Cheng RYS; Ridnour LA; Fujita M; Lockett SJ; Anderson SK; McVicar DW; Wink DA
Br J Pharmacol; 2019 Jan; 176(2):155-176. PubMed ID: 30152521
[TBL] [Abstract][Full Text] [Related]
2. Coexpression of NOS2 and COX2 accelerates tumor growth and reduces survival in estrogen receptor-negative breast cancer.
Basudhar D; Glynn SA; Greer M; Somasundaram V; No JH; Scheiblin DA; Garrido P; Heinz WF; Ryan AE; Weiss JM; Cheng RYS; Ridnour LA; Lockett SJ; McVicar DW; Ambs S; Wink DA
Proc Natl Acad Sci U S A; 2017 Dec; 114(49):13030-13035. PubMed ID: 29087320
[TBL] [Abstract][Full Text] [Related]
3. Nitric oxide is not just blowing in the wind.
Ignarro LJ
Br J Pharmacol; 2019 Jan; 176(2):131-134. PubMed ID: 30556130
[TBL] [Abstract][Full Text] [Related]
4. Nitric oxide synthase enzymology in the 20 years after the Nobel Prize.
Stuehr DJ; Haque MM
Br J Pharmacol; 2019 Jan; 176(2):177-188. PubMed ID: 30402946
[TBL] [Abstract][Full Text] [Related]
5. NOS2 and COX-2 Co-Expression Promotes Cancer Progression: A Potential Target for Developing Agents to Prevent or Treat Highly Aggressive Breast Cancer.
Coutinho LL; Femino EL; Gonzalez AL; Moffat RL; Heinz WF; Cheng RYS; Lockett SJ; Rangel MC; Ridnour LA; Wink DA
Int J Mol Sci; 2024 Jun; 25(11):. PubMed ID: 38892290
[TBL] [Abstract][Full Text] [Related]
6. Inducible nitric oxide synthase-derived extracellular nitric oxide flux regulates proinflammatory responses at the single cell level.
Somasundaram V; Gilmore AC; Basudhar D; Palmieri EM; Scheiblin DA; Heinz WF; Cheng RYS; Ridnour LA; Altan-Bonnet G; Lockett SJ; McVicar DW; Wink DA
Redox Biol; 2020 Jan; 28():101354. PubMed ID: 31683257
[TBL] [Abstract][Full Text] [Related]
7. Endothelial NOS: perspective and recent developments.
Garcia V; Sessa WC
Br J Pharmacol; 2019 Jan; 176(2):189-196. PubMed ID: 30341769
[TBL] [Abstract][Full Text] [Related]
8. Interferon-gamma is quintessential for NOS2 and COX2 expression in ER
Cheng RYS; Ridnour LA; Wink AL; Gonzalez AL; Femino EL; Rittscher H; Somasundaram V; Heinz WF; Coutinho L; Rangel MC; Edmondson EF; Butcher D; Kinders RJ; Li X; Wong STC; McVicar DW; Anderson SK; Pore M; Hewitt SM; Billiar TR; Glynn SA; Chang JC; Lockett SJ; Ambs S; Wink DA
Cell Death Dis; 2023 May; 14(5):319. PubMed ID: 37169743
[TBL] [Abstract][Full Text] [Related]
9. Systemic Nos2 Depletion and Cox inhibition limits TNBC disease progression and alters lymphoid cell spatial orientation and density.
Somasundaram V; Ridnour LA; Cheng RY; Walke AJ; Kedei N; Bhattacharyya DD; Wink AL; Edmondson EF; Butcher D; Warner AC; Dorsey TH; Scheiblin DA; Heinz W; Bryant RJ; Kinders RJ; Lipkowitz S; Wong ST; Pore M; Hewitt SM; McVicar DW; Anderson SK; Chang J; Glynn SA; Ambs S; Lockett SJ; Wink DA
Redox Biol; 2022 Dec; 58():102529. PubMed ID: 36375380
[TBL] [Abstract][Full Text] [Related]
10. Nitric Oxide Synthase-2-Derived Nitric Oxide Drives Multiple Pathways of Breast Cancer Progression.
Basudhar D; Somasundaram V; de Oliveira GA; Kesarwala A; Heinecke JL; Cheng RY; Glynn SA; Ambs S; Wink DA; Ridnour LA
Antioxid Redox Signal; 2017 Jun; 26(18):1044-1058. PubMed ID: 27464521
[TBL] [Abstract][Full Text] [Related]
11. Nitric oxide in the gastrointestinal tract: opportunities for drug development.
Wallace JL
Br J Pharmacol; 2019 Jan; 176(2):147-154. PubMed ID: 30357812
[TBL] [Abstract][Full Text] [Related]
12. NO as a multimodal transmitter in the brain: discovery and current status.
Garthwaite J
Br J Pharmacol; 2019 Jan; 176(2):197-211. PubMed ID: 30399649
[TBL] [Abstract][Full Text] [Related]
13. Inhaled nitric oxide.
Yu B; Ichinose F; Bloch DB; Zapol WM
Br J Pharmacol; 2019 Jan; 176(2):246-255. PubMed ID: 30288739
[TBL] [Abstract][Full Text] [Related]
14. Oiling the wheels of discovery.
Flower RJ
Br J Pharmacol; 2019 Apr; 176(8):985-987. PubMed ID: 30953367
[TBL] [Abstract][Full Text] [Related]
15. Nitric oxide and its role as a non-adrenergic, non-cholinergic inhibitory neurotransmitter in the gastrointestinal tract.
Sanders KM; Ward SM
Br J Pharmacol; 2019 Jan; 176(2):212-227. PubMed ID: 30063800
[TBL] [Abstract][Full Text] [Related]
16. Tumor microenvironment-based feed-forward regulation of NOS2 in breast cancer progression.
Heinecke JL; Ridnour LA; Cheng RY; Switzer CH; Lizardo MM; Khanna C; Glynn SA; Hussain SP; Young HA; Ambs S; Wink DA
Proc Natl Acad Sci U S A; 2014 Apr; 111(17):6323-8. PubMed ID: 24733928
[TBL] [Abstract][Full Text] [Related]
17. Nitric oxide synthase 2 and cyclooxygenase 2 interactions in inflammation.
Weinberg JB
Immunol Res; 2000; 22(2-3):319-41. PubMed ID: 11339365
[TBL] [Abstract][Full Text] [Related]
18. Nitric oxide and hydrogen sulfide: the gasotransmitter paradigm of the vascular system.
Cirino G; Vellecco V; Bucci M
Br J Pharmacol; 2017 Nov; 174(22):4021-4031. PubMed ID: 28407204
[TBL] [Abstract][Full Text] [Related]
19. Molecular Mechanisms of Nitric Oxide in Cancer Progression, Signal Transduction, and Metabolism.
Somasundaram V; Basudhar D; Bharadwaj G; No JH; Ridnour LA; Cheng RYS; Fujita M; Thomas DD; Anderson SK; McVicar DW; Wink DA
Antioxid Redox Signal; 2019 Mar; 30(8):1124-1143. PubMed ID: 29634348
[TBL] [Abstract][Full Text] [Related]
20. LncRNA HEIH/miR-939-5p interplay modulates triple-negative breast cancer progression through NOS2-induced nitric oxide production.
Nafea H; Youness RA; Abou-Aisha K; Gad MZ
J Cell Physiol; 2021 Jul; 236(7):5362-5372. PubMed ID: 33368266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
